medline.ch Respirationstrakt Neoplasie

	Completely robotic right Pancoast tumour resection with en bloc right upper lobectomy and chest wall resection using a high-speed pneumatic drill. Multimed Man Cardiothorac Surg Saad HS, Kouritas VK. PMID: 41944546 [PubMed - indexed for MEDLINE]
	Optimizing Surgery Strategies in Stage IB Lung Squamous Cell Carcinoma: Insights from Interpretable Machine Learning. Thorac Cancer Ding Q, Lin C, Lam Y, Guo F, Ma S, Qiang G. PMID: 41943992 [PubMed - indexed for MEDLINE]
	Injectable hydrogel-based platforms for precision lung cancer therapy: bridging biomaterials and oncology. J Biomater Sci Polym Ed Swarn S, Parmar V, Verma A, Kumar V, Chaubey KK, Gandhi SM, Kapoor D. PMID: 41943457 [PubMed - as supplied by publisher]
	A novel diagnostic model combining ProGRP and inflammatory biomarkers for early detection of lung cancer: development and validation in treatment-naive cohorts. BMC Cancer Ma J, Zhu S, Li X, Gao S, Geng Y. PMID: 41943036 [PubMed - as supplied by publisher]
	The optimal duration of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer: a systematic review of clinical trials. BMC Pulm Med Guo W, Li Y, Dai L, Jia Y, Tong M, Li J, Jiang T. PMID: 41942994 [PubMed - as supplied by publisher]
	Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice. BMC Cancer Vázquez-Quiroga S, García-Martínez S, Jiménez-Meseguer M, Irusta-Gonzalo A, Jáñez-Carrera R, Otero-Espinar FJ, Ruiz-Martín G, García-Díaz B, López-Martín A, Peña-Cabia S. PMID: 41942936 [PubMed - as supplied by publisher]
	A preliminary study on the prognostic impact of platelet to monocyte ratio and its related genes on non-small cell lung cancer. BMC Cancer Tang Y, Huang Y, Chen L, Huang Z, Huang X, He Z. PMID: 41942911 [PubMed - as supplied by publisher]
	European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids. J Neuroendocrinol Baudin E, Durand A, Buikhuisen W, Capdevila J, Caplin M, Deroose CM, Dromain C, Faggiano A, Filosso PL, Kaltsas G, Volante M, Walter T, Garcia-Carbonero R. PMID: 41941890 [PubMed - indexed for MEDLINE]
	Ki-67 with Neutrophil-to-lymphocyte and CD4-positive/CD8-positive Ratios Predicts Early Response in Non-small Cell Lung Cancer. J Vis Exp Guo Q, Cai J, Zhou L, Cai L. PMID: 41941377 [PubMed - indexed for MEDLINE]
	Analysis of the safety and feasibility of subcutaneous areolar tunnel single-port thoracoscopic radical resection for lung cancer: a retrospective cohort study. Updates Surg Yang K, Li K, Guo C, Que C, Zuo Z, Wang J, Wang Q, Jin D, Gou Y, Wang C. PMID: 41941060 [PubMed - as supplied by publisher]
	Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer. Discov Oncol Jiang X, Zheng M, Zhang L, Xu D, Cheng J, Deng H, Wei C, Xian J, Xu F, Maghsoudloo M, Li D, Ma W, Fu J. PMID: 41941024 [PubMed - as supplied by publisher]
	Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study. Future Oncol Oduah EI, Zhang T, Jung SH, Stinchcombe TE, Ready N, Crawford J, Clarke JM, Gray JE, Antonia SJ. PMID: 41940540 [PubMed - as supplied by publisher]
	Accuracy of Radiomics-Based Machine Learning for Predicting Risk of Recurrence in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis. J Med Internet Res Wu J, Zhang Y, Wang J, Chen C, Hu S, Chen W. PMID: 41940422 [PubMed - indexed for MEDLINE]
	Decoding macrophage heterogeneity in the pulmonary fibrosis lung cancer transition. Front Immunol Yu H, Zhao M, Li Q, Zhang Y. PMID: 41939908 [PubMed - indexed for MEDLINE]
	Case Report: A case of diabetes mellitus and pneumonitis induced by envafolimab treatment in small cell lung cancer. Front Immunol Li Y, Wang H, Xing G, Guo X, Yi S. PMID: 41939902 [PubMed - indexed for MEDLINE]
	Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management. Front Pharmacol Nardin S, Vezzoli F, Cognolato G, Mollace R, Ramella Pollone B, Biello F, Cao D, Tagliamento M, Sarocchi M, Pagnesi M, Verdoia M, Conte B, Grisanti S, Genova C, Gennari A, Nardin M. PMID: 41939827 [PubMed]
	Correction: Prevalence and survival implications of CT-defined low skeletal muscle mass in lung cancer: a systematic review and meta-analysis. Front Oncol Tao Z, Yi B, Wu Q, Luo Y, Zhou C. PMID: 41939477 [PubMed]
	Prevalence and survival implications of CT-defined low skeletal muscle mass in lung cancer: a systematic review and meta-analysis. Front Oncol Tao Z, Yi B, Wu Q, Luo Y, Zhou C. PMID: 41939462 [PubMed]
	Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study. Lancet Reg Health West Pac Yu Y, Guo Q, Zhang Y, Fang J, Zhong D, Liu B, Pan P, Lv D, Wu L, Zhao Y, Li J, Liu Z, Liu C, Su H, Fan Y, Zhang T, Liu A, Jin B, Wang Y, Zhou J, Zhang Z, Ran F, Song X, Shi MM, Su W, Lu S, study group. PMID: 41938023 [PubMed]
	Tumor size as a key determinant of treatment strategy and prognosis in stereotactic body radiotherapy for pulmonary metastases: a retrospective study. Rep Pract Oncol Radiother Okuma K, Kashihara T, Inaba K, Takahashi K, Sakuramachi M, Nagao A, Yoshiba A, Kobori A, Gao T, Nakamura S, Igaki H. PMID: 41937881 [PubMed]

Artikel 1 - 20 / 158649

Seite 1 von 7933



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung